iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
72 hedge funds and large institutions have $56.8M invested in iShares Genomics Immunology and Healthcare ETF in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 22
Holders
72
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.18M | |
| 2 | +$1.8M | |
| 3 | +$1.37M | |
| 4 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$1.2M |
| 5 |
Goldman Sachs
New York
|
+$1.11M |
Top Sellers
| 1 | -$5.87M | |
| 2 | -$1.53M | |
| 3 | -$1.49M | |
| 4 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
-$1.11M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$916K |